What is the official website of Grupa NEUCA ?

The official website of Grupa NEUCA is https://kariera.neuca.pl.

What is Grupa NEUCA's cybersecurity risk score?

Grupa NEUCA has an AI-generated cybersecurity risk score of 762 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Grupa NEUCA experienced?

According to Rankiteo, Grupa NEUCA currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Grupa NEUCA been affected by any supply chain cyber incidents ?

According to Rankiteo, Grupa NEUCA has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Grupa NEUCA have SOC 2 Type 1 certification ?

According to Rankiteo, Grupa NEUCA is not certified under SOC 2 Type 1.

Does Grupa NEUCA have SOC 2 Type 2 certification ?

According to Rankiteo, Grupa NEUCA does not hold a SOC 2 Type 2 certification.

Does Grupa NEUCA comply with GDPR ?

According to Rankiteo, Grupa NEUCA is not listed as GDPR compliant.

Does Grupa NEUCA have PCI DSS certification ?

According to Rankiteo, Grupa NEUCA does not currently maintain PCI DSS compliance.

Does Grupa NEUCA comply with HIPAA ?

According to Rankiteo, Grupa NEUCA is not compliant with HIPAA regulations.

Does Grupa NEUCA have ISO 27001 certification ?

According to Rankiteo,Grupa NEUCA is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Grupa NEUCA operate in ?

Grupa NEUCA operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Grupa NEUCA have ?

Grupa NEUCA employs approximately 2,737 people worldwide.

Does Grupa NEUCA own any subsidiaries ?

Grupa NEUCA presently has no subsidiaries across any sectors.

How many LinkedIn followers does Grupa NEUCA have ?

Grupa NEUCA's official LinkedIn profile has approximately 41,487 followers.

What is the NAICS classification code for Grupa NEUCA ?

Grupa NEUCA is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Grupa NEUCA have a Crunchbase profile ?

No, Grupa NEUCA does not have a profile on Crunchbase.

Does Grupa NEUCA have a LinkedIn profile ?

Yes, Grupa NEUCA maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/neuca-sa.

How many cybersecurity incidents has Grupa NEUCA experienced ?

As of October 16, 2026, Rankiteo reports that Grupa NEUCA has not experienced any cybersecurity incidents.

How many peer or competitor companies does Grupa NEUCA have ?

Grupa NEUCA has an estimated 5,773 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Grupa NEUCA

Boost Score +25 with badge (5 left)

762

/1000

Fair

787

/1000

Fair

Grupa NEUCA Vendor Cyber Rating & Cyber Score

neuca.pl

Add Your Compliance Badge

Grupa NEUCA działa na rynku ochrony zdrowia. Tworzymy nową jakość usług, produktów i serwisów we wszystkich jego obszarach. Działamy na rynku od ponad 30 lat, łącząc potrzeby farmaceutów, producentów i pacjentów. Jesteśmy liderem dystrybucji farmaceutyków w Polsce, kompleksowo wspieramy niezależne apteki. Tworzymy wysokiej jakości leki na receptę, suplementy diety i dermokosmetyki. Oferujemy bogate portfolio usług medycznych w ramach zintegrowanego systemu opieki zdrowotnej. W zakresie badań klinicznych, zwiększamy dostęp do innowacyjnych terapii, tworząc spójny strumień danych między pacjentami, badaczami i ośródkami badawczymi. Jedna firma, tyle kierunków rozwoju: 🏥 Opieka medyczna w Centrach Medycznych Świat Zdrowia 👨‍⚕️

Grupa NEUCA

Grupa NEUCA CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Grupa NEUCA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Grupa NEUCA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Grupa NEUCA in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Grupa NEUCA in 2026.

Incident Types Grupa NEUCA vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Grupa NEUCA in 2026.

Incident History - Grupa NEUCA (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Grupa NEUCA Subsidiaries

Grupa NEUCA

Pharmaceutical Manufacturing

Website: https://kariera.neuca.pl

Company Size: 5,001-10,000 employees

KapadiResearch Services

Clinscience (now Kapadi)Research Services

PratiaResearch

OncoBay Clinical (now Kapadi)Research Services

Exom Group (now Kapadi)Pharmaceutical Manufacturing

Loading…

Grupa NEUCA Similar Companies

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Loading…

NEWS

Grupa NEUCA CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-111369

SUMMARY

ClassroomIO through 1.0.0 contains an incorrect authorization vulnerability in the PUT and DELETE /:lessonId lesson routes that allows any course member, including students, to modify lessons. Authenticated students can supply arbitrary lesson ids to change titles and stored HTML content or delete lessons in their course and in other courses and organizations.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:L

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-111368

SUMMARY

ClassroomIO through 1.0.0 contains an insecure direct object reference vulnerability in the Hono API course submission routes that allows course tutors or admins to modify submissions in other courses. Attackers can supply their own course id with another course's submission UUID to PUT or DELETE handlers to overwrite answers, grades, feedback, and grading status or delete submissions.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 6.4)

cvss3

Base Score: 6.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:H/A:L

cvss4

Base Score: 6.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

1.6

REFERENCES

CVE-2026-111367

SUMMARY

BillionMail through 4.9 contains a hard-coded cryptographic key vulnerability that allows unauthenticated attackers to forge unsubscribe and subscribe-confirm JWTs by computing the key from shipped configuration constants. Attackers can submit forged tokens to /api/unsubscribe, /api/unsubscribe_new, or /api/subscribe/confirm to deactivate any contact or force confirmed subscriptions.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-111366

SUMMARY

cool-admin-midway through 8.0.0 contains an authorization bypass vulnerability that allows department-limited admins to manage users outside their departments by supplying arbitrary user ids. Attackers holding sys:user:* permissions can call /admin/sys/user/info, update, or delete to read records, reset passwords and roles, or delete accounts.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 7.2)

cvss3

Base Score: 7.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

1.2

REFERENCES

CVE-2026-111365

SUMMARY

cool-admin-midway through 8.0.0 contains an authorization bypass vulnerability that allows non-superadmin admins to read, modify, or delete other admins' roles by supplying arbitrary role ids. Attackers holding ordinary sys:role permissions can call /admin/sys/role/info, update, or delete with another admin's role id to rewrite menu and department grants, changing other users' effective access.

Published

Date2026-10-15

Updated

Date2026-10-15

RISK INFORMATION (Score: 6)

cvss3

Base Score: 6.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:H/A:L

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Grupa NEUCA Vendor Cyber Rating & Cyber Score

Grupa NEUCA A.I CyberSecurity Scoring

Grupa NEUCA CyberSecurity News & History

Grupa NEUCA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Grupa NEUCA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Grupa NEUCA vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Grupa NEUCA (X = Date, Y = Severity)

Grupa NEUCA Subsidiaries

Grupa NEUCA

Grupa NEUCA Similar Companies

Astellas Pharma

MSD

Teva Pharmaceuticals

Lupin

Sandoz

MACLEODS PHARMACEUTICALS LTD.

MENARINI Group

Dr. Reddy's Laboratories

Ipca Laboratories Limited

Grupa NEUCA CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Grupa NEUCA CyberSecurity News & History

Grupa NEUCA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Grupa NEUCA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Grupa NEUCA vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Grupa NEUCA (X = Date, Y = Severity)

Grupa NEUCA Subsidiaries

Grupa NEUCA

Grupa NEUCA Similar Companies

Astellas Pharma

MSD

Teva Pharmaceuticals

Lupin

Sandoz

MACLEODS PHARMACEUTICALS LTD.

MENARINI Group

Dr. Reddy's Laboratories

Ipca Laboratories Limited

Grupa NEUCA CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo